Sign in
CompletedNo phase

Retrospective Observational Study on GERD Management in General Hospitals in Korea

Key facts

Who runs it
Chong Kun Dang Pharmaceutical
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
13,750 people enrolled
Started
3 Jan 2018
Ended
31 Dec 2024
Type of study
Observational
Record updated
16 May 2025

Who can take part

Age
19 years and older
Sex
Women and men

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients aged 19 years or older as of the date of their first visit
  • Patients who visited domestic general hospitals (secondary and tertiary healthcare institutions) at least twice between January 1, 2018, and August 31, 2020, for the diagnosis or treatment of GERD

Who cannot take part

  • Patients with no GERD treatment information recorded in the medical records, even once
  • Patients deemed inappropriate for participation by the investigator (e.g., when the overall GERD diagnosis/treatment information is missing from the medical records)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A RetrospectiVe ObservatIoNal Study of a CurrEnt Status and Its Management of GERD (GastroEsophageal Reflux Disease) in General HOspitals in Korea
Record updated
16 May 2025